$2.710
-0.010 (-0.37%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CMMB por análisis de gráficos similares
Alphio's CMMB stock price prediction model matches the current Chemomab Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.70 (-0.27%). The 1-week path is $2.82 (+4.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Chemomab Therapeutics Ltd?
Chemomab Therapeutics Ltd (CMMB) is a good buy right now due to its recent price increase of 25.46% over the last 5 days and a strong RSI of 94.74, suggesting momentum. The company is also preparing for a Phase 3 trial for its lead drug candidate, which could significantly enhance its market position. However, the main risk is its negative net income, which was -2,165,000 USD in Q2 2026, indicating ongoing financial losses.
CMMB cerró en $2.71 el Friday, tras bajar -0.37%
Chemomab Therapeutics Ltd (CMMB) last closed at $2.71, losing -0.37%. These facts feed the 1-day and 1-week CMMB price prediction above.
Factores de la previsión
Los factores de la previsión de Chemomab Therapeutics Ltd (CMMB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CMMB, ordenadas por similitud.
Análisis de estacionalidad de CMMB
Historically the probability of a positive August return for CMMB is 61.90%. August offers the highest probability of a positive month at 61.90%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CMMB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.28 | $1.35 | $1.39 | -50.17% |
| Sep 2026 | $1.12 | $1.16 | $1.32 | -57.27% |
| Oct 2026 | $1.05 | $1.11 | $1.19 | -58.95% |
| Nov 2026 | $1.06 | $1.07 | $1.13 | -60.58% |
| Dec 2026 | $1.01 | $1.21 | $1.23 | -55.44% |
En 2026, se proyecta que Chemomab Therapeutics Ltd (CMMB) oscile entre $1.01 y $1.39.
Previsión mensual de Chemomab Therapeutics Ltd para 2026
En Aug de 2026, se proyecta que Chemomab Therapeutics Ltd promedie $1.35, con un mínimo de $1.28 y un máximo de $1.39.
En Sep de 2026, se proyecta que Chemomab Therapeutics Ltd promedie $1.16, con un mínimo de $1.12 y un máximo de $1.32.
En Oct de 2026, se proyecta que Chemomab Therapeutics Ltd promedie $1.11, con un mínimo de $1.05 y un máximo de $1.19.
En Nov de 2026, se proyecta que Chemomab Therapeutics Ltd promedie $1.07, con un mínimo de $1.06 y un máximo de $1.13.
En Dec de 2026, se proyecta que Chemomab Therapeutics Ltd promedie $1.21, con un mínimo de $1.01 y un máximo de $1.23.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.